Drugs / ASA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03047837 | Mar 2017 → Mar 2024 | colorectal cancer | Ente Ospedaliero Ospedali Galliera | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03047837 ↗ |
| Action | Inhibit | “ASA is an inhibitor of mTOR/S6K1” NCT03047837 ↗ |